Parnax Lab Ltd (506128)

₹113.1▲0.88%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

Parnax Lab Ltd share Performance

₹112.55
₹116.5
₹113.1
0.49%
Low
Day's Volatility:3.49%
High
3.01%
₹55
₹167.9
₹113.1
51.37%
Low
52 Weeks Volatility:99.82%
High
48.45%

Returns %
1 Month Return	-16.16 %
3 Month Return	+ 25.25 %
1 Year Return	+ 64.74 %

Market Stats
Previous Close	₹₹114.10
Open	₹₹112.75
Volume	₹6,282.00
Upper Circuit	₹-
Lower Circuit	₹-
Market Cap	₹₹131.05Cr

Company Information

KrishnaDeep Trade and Investment Limited is a Mumbai-based financing and investment company with over 38 years of experience in the industry. Established in 1982, the company provides a wide range of financial activities within India, including investment advisory services, asset financial management, and portfolio building. The company takes pride in its professional and experienced staff, with highly skilled and knowledgeable experts in the relevant fields to ensure the best solutions for its clients. KrishnaDeep Trade and Investment Limited has demonstrated exceptional success over the past 38 years, making it a reliable and trustworthy partner for its customers. With an eye to the future, the company continually strives to improve its services and provide innovative, top-of-the-line expertise in the finance and investment sector.

Share Price: ₹113.10 per share as on 16 May, 2024 04:01 PM
Market Capitalisation: ₹131.05Cr as of today
Revenue: ₹50.99Cr as on December 2023 (Q4 23)
Net Profit: ₹2.18Cr as on December 2023 (Q4 23)
Listing date: 01 Jan, 0001

Organisation	Parnax Lab Ltd
Headquarters
Industry	Pharmaceuticals
E-voting on shares	Click here to vote

Fundamentals of Parnax Lab Ltd

Insights on Parnax Lab Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 42.83 Cr → 51.09 Cr (in ₹), with an average increase of 16.2% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 1.87 Cr → 2.18 Cr (in ₹), with an average increase of 14.2% per quarter
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, Parnax Lab has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.30% of holdings in Mar 2024 quarter
NO EFFECT
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 93.2% return, outperforming this stock by 28.5%
NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 27.70% of holdings in Mar 2024 quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, Parnax Lab stock has moved down by -16.2%